FDA Approved: OCTREOTIDE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for octreotide acetate from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Carcinoid Syndrome
• Gastrointestinal Neuroendocrine Tumor
• Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor
• Vipoma

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

SUPPL AP for OCTREOTIDE (OCTREOTIDE ACETATE)